Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Total	Royalty Settlement [Domain]	Common Stock	Common Stock Royalty Settlement [Domain]	Additional Paid-In Capital	Additional Paid-In Capital Royalty Settlement [Domain]	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024			399,236,000
Beginning balance at Dec. 31, 2024	$ 1,123,252		$ 3,992		$ 4,181,521		$ (3,062,261)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	33,353						33,353
Stock issued during period, acquisitions (in shares)			239,489,000
Stock issued during period, acquisitions	1,590,091		$ 2,395		1,587,696
Common stock issued for investment (in shares)				595,000
Common stock issued		$ 3,655		$ 6		$ 3,649
Common stock issued/canceled under long-term incentive plans, annual incentive plans, director fees and options, net (in shares)			(259,000)
Common stock issued/canceled under long-term incentive plans, annual incentive plans, director fees and options, net	(1,839)		$ (3)		(1,836)
Ending balance (in shares) at Mar. 31, 2025			639,061,000
Ending balance at Mar. 31, 2025	2,748,512		$ 6,390		5,771,030		(3,028,908)
Beginning balance (in shares) at Dec. 31, 2024			399,236,000
Beginning balance at Dec. 31, 2024	1,123,252		$ 3,992		4,181,521		(3,062,261)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	104,079						104,079
Ending balance (in shares) at Jun. 30, 2025			642,702,000
Ending balance at Jun. 30, 2025	2,828,387		$ 6,426		5,780,143		(2,958,182)
Beginning balance (in shares) at Mar. 31, 2025			639,061,000
Beginning balance at Mar. 31, 2025	2,748,512		$ 6,390		5,771,030		(3,028,908)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	70,726						70,726
Stock options exercised (in shares)			2,139,000
Stock options exercised	7,222		$ 21		7,201
Stock repurchase program (in shares)			(216,000)
Stock repurchase program	(2,004)		$ (2)		(2,002)
Common stock issued/canceled under long-term incentive plans, annual incentive plans, director fees and options, net (in shares)			1,718,000
Common stock issued/canceled under long-term incentive plans, annual incentive plans, director fees and options, net	3,931		$ 17		3,914
Ending balance (in shares) at Jun. 30, 2025			642,702,000
Ending balance at Jun. 30, 2025	2,828,387		$ 6,426		5,780,143		(2,958,182)
Beginning balance (in shares) at Dec. 31, 2025			642,093,000
Beginning balance at Dec. 31, 2025	3,313,051		$ 6,421		5,783,019		(2,476,389)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	246,761						246,761
Stock issued during period, acquisitions (in shares)			392,682,000
Stock issued during period, acquisitions	6,938,701		$ 3,927		6,934,774
Stock options exercised (in shares)			45,000
Stock options exercised	160		$ 0		160
Common stock issued/canceled under long-term incentive plans, annual incentive plans, director fees and options, net (in shares)			(323,000)
Common stock issued/canceled under long-term incentive plans, annual incentive plans, director fees and options, net	(86,348)		$ (3)		(86,345)
Ending balance (in shares) at Mar. 31, 2026			1,034,497,000
Ending balance at Mar. 31, 2026	10,412,325		$ 10,345		12,631,608		(2,229,628)
Beginning balance (in shares) at Dec. 31, 2025			642,093,000
Beginning balance at Dec. 31, 2025	3,313,051		$ 6,421		5,783,019		(2,476,389)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 368,614						368,614
Stock options exercised (in shares)	77,616
Ending balance (in shares) at Jun. 30, 2026			1,028,536,000
Ending balance at Jun. 30, 2026	$ 10,409,504		$ 10,285		12,527,639		(2,128,420)
Beginning balance (in shares) at Mar. 31, 2026			1,034,497,000
Beginning balance at Mar. 31, 2026	10,412,325		$ 10,345		12,631,608		(2,229,628)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	121,853						121,853
Stock options exercised (in shares)			32,000
Stock options exercised	126		$ 0		126
Stock repurchase program (in shares)			(5,982,000)
Stock repurchase program	(110,422)		$ (60)		(110,362)
Dividend payment	(20,645)						(20,645)
Common stock issued/canceled under long-term incentive plans, annual incentive plans, director fees and options, net (in shares)			(11,000)
Common stock issued/canceled under long-term incentive plans, annual incentive plans, director fees and options, net	6,267		$ 0		6,267
Ending balance (in shares) at Jun. 30, 2026			1,028,536,000
Ending balance at Jun. 30, 2026	$ 10,409,504		$ 10,285		$ 12,527,639		$ (2,128,420)